On this page
Digibind
Digoxin Immune Fab (Ovine)
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Digibind
Proper name
Digoxin Immune Fab (Ovine)
Licence type
351(a)
BLA number
103141
Applicant
Wellcome Foundation Limited Wellcome Research Laboratories
Center
CBER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 38MG | For Injection | Intravenous | Single-Dose Vial | Disc | April 22, 1986 |
Exclusivity
Source: Purple Book| Kind | Expires |
|---|---|
| Orphan exclusivity | April 22, 1993 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |